Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance
about
Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectivenessExposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaquesHow Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactChallenges for HIV pre-exposure prophylaxis among men who have sex with men in the United States.A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns.Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role.How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention.A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve populationDeciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention.Impact of Population Recruitment on the HIV Epidemics and the Effectiveness of HIV Prevention InterventionsCost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States.Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project.Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.HIV treatment, preexposure prophylaxis, and drug resistance: reconciling conflicting predictions from mathematical models.Methodological concerns regarding a PrEP model.HIV transmission and pre-exposure prophylaxis in a high risk MSM population: A simulation study of location-based selection of sexual partners.The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco.A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and eliminationAdding Education to “Test and Treat”: Can We Overcome Drug Resistance?
P2860
Q26825761-F424CC45-5D67-4442-86B9-F9313F900A58Q28535414-EDDCCA03-17DA-4B7D-89E8-30490ADF08E6Q28540200-7691E0A5-9FBC-4973-9597-38363AC585B8Q28552455-8A50C527-EFFF-43A7-87B8-850844C00E8CQ34395187-BBA18669-9289-4D72-9097-0442FE10F511Q34573789-49EDD483-6FCE-4F61-BD01-DF230BD58179Q35575958-AACB3740-A994-4F24-AFC9-6EFEAB7564C2Q35583501-96EFA706-C588-425D-B83D-78432675078DQ36204616-6DA642C8-AEEA-47DF-87DC-9DCD13D30A33Q36611180-F3A9F92E-4D09-4506-8261-2588BFC5D954Q37305607-B53B28F4-73B4-483C-A5D3-0094A49E153DQ39321915-2D27EE8A-767C-457F-894F-3169ACA58004Q39825094-9A717726-F2BF-4B01-A863-183F7FF60446Q40446068-B419C50D-9625-4A2E-83FE-0F1BC5D4F096Q40668946-BFE41FC1-6F56-49E2-96F1-E1C2C6B63CDFQ42792046-71E113E6-5680-4504-862F-35A5DC86FDD2Q46035222-A4EBD79B-CFE3-4E2D-80FE-ECCAB76FAC43Q47162251-6C839991-52A5-4C96-A228-758C3F6D4F3CQ47613648-983FF0E2-6DF8-48F1-BB16-8D6DCEF94154Q52567034-82CFA68A-B75E-4391-9A57-73B15C5CC8CBQ58099099-D1DC6701-85A2-4DED-A505-567960C9FECCQ59111970-B0FDE5DC-359C-41E1-A5E0-55FF1259523D
P2860
Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Modeling dynamic interactions ...... HIV transmission & resistance
@ast
Modeling dynamic interactions ...... HIV transmission & resistance
@en
type
label
Modeling dynamic interactions ...... HIV transmission & resistance
@ast
Modeling dynamic interactions ...... HIV transmission & resistance
@en
prefLabel
Modeling dynamic interactions ...... HIV transmission & resistance
@ast
Modeling dynamic interactions ...... HIV transmission & resistance
@en
P2093
P2860
P356
P1433
P1476
Modeling dynamic interactions ...... HIV transmission & resistance
@en
P2093
Godfrey Musuka
James S Kahn
Lesego Busang
Meagan Barrett
Themba Lebogang Moeti
Virginie Supervie
P2860
P2888
P356
10.1038/SREP00185
P407
P50
P577
2011-12-07T00:00:00Z